Abbott to withdraw Alpine and Absorb, awaiting Govt.'s revie
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Health-care major Abbott has decided to withdraw two types of stents from the Indian market in the wake of the drug price regulator's move to cap prices. The company has applied to the National Pharmaceutical Pricing Authority (NPPA) seeking to withdraw the two types - the Alpine drug eluting stent and the Absorb dissolving stent. However, the two stents will continue to remain available while the government reviews our application. There is no shortage of Abbott stents as of now.

The company took into consideration the higher manufacturing costs and other associated costs of the two types of stents. According to the company, it will continue to make available all other XIENCE coronary stent products within the ceiling price set by the NPPA.

https://www.telegraphindia.com/1170422/jsp/nation/story_147673.jsp#.WPsfCtqGPIV
Preview
Like
Comment
Share